KathleenMullaneDOPharm. D.

Infectious Disease • Riverside, IL

HIV/AIDS Medicine, Transplant/Immunocompromised States

Medical Director, PPD; a division of Thermo-Fischer Professor of Medicine; University of Chicago Department of Medicine; Section of Infectious Diseases

Join to view full profile

Dr. Mullane is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mullane's full profile

Already have an account?

Office
374 Bartram Rd
M/C 5065
Riverside, IL 60546
Phone+1 708-227-5299

Fax+1 773-702-8998

Summary

Dr. Kathleen Mullane is an Infectious Disease specialist in Chicago, IL. She is a Medical Director for PPD, a division of Thermo-Fischer in the department of Pharmacovigilance and is affiliated with University of Chicago Medical Center. She received her medical degree from Midwestern University / Chicago College of Osteopathic Medicine and has been in practice 28 years.
Clinically, she specializes in transplant /immunocompromised infectious disease states and is experienced in general infectious diseases, HIV, COVID-19, C. difficile colitis, healthcare outcomes research. In clinical trials research she has participated in trials involving vaccines, antifungal agents, antiviral agents and antibacterial agents.

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Infectious Disease, 1992 - 1994
University of ChicagoFellowship, Infectious Disease, 1992 - 1994
Rush University Medical CenterResidency, Internal Medicine, 1989 - 1992
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1989
University of Illinois College of Medicine at ChicagoPharm D, Clinical Pharmacy, 1982 - 1983
Philadelphia College of Pharmacy and SciencesPharm D, Clinical Pharmacy, 1980 - 1982
University of IowaBS Pharmacy, Pharmacy, 1977 - 1980

Certifications & Licensure

IL State License 1980 - 2026
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Top Doctor Chicago Magazine, 2012, 2020-2023
Top Doctor Castle Connelly / US News and World Report, 2012-2023
Top Doctor US News and World Report, 2012-2023
Distinguished Service Award University of Chicago, Department of Medicine, 2020
Senior Clinician of the Year University of Chicago, 2019
Top Internist in Illinois Award Health Tap, 2014
Top Doctor Health Tap, 2013
Top Doctor Vitals, 2013
Top Infectious Disease Specialist in Illinois Award Health Tap, 2013
Inspirational Attending of the Year Loyola University Medical Center, 2004
Trainee Investigator Award American Society for Clinical Research, 1994
Special VA Commendation for Service Award Jessie Brown VAMC, 1985
The Smith Kline and French Laboratory Award University of Iowa College of Pharmacy, 1980
Join now to see all

Clinical Trials

DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) Start of enrollment: 2006 May 01
Terminated
Phase 3
A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
Completed
Phase 3
Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection Start of enrollment: 2014 Mar 01
Completed
Phase 3
The Chimerix CMX001 Registry Start of enrollment: 2014 Jan 01
Terminated
SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
Completed
Phase 2
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Start of enrollment: 2015 Jun 01
Completed
Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options Start of enrollment: 2018 Jun 06
Recruiting
Phase 2
Study to Evaluate the Safety and Efficacy of the Coadministration of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis Start of enrollment: 2019 Jan 22
Completed
Phase 2
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection Start of enrollment: 2019 Aug 02
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

708 citations
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Francisco M. Marty, Per Ljungman, Roy F. Chemaly, Johan Maertens, Sanjeet Dadwal
The New England Journal of Medicine. 2017-12-06
132 citations
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.
Roy F. Chemaly, Sunwen Chou, Hermann Einsele, Paul D. Griffiths, Robin K. Avery
Clinical Infectious Diseases. 2019-04-08
137 citations
Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study
Robert Orenstein, Erik R. Dubberke, Robert Hardi, Arnab Ray, Kathleen M. Mullane
Clinical Infectious Diseases. 2016-03-01

Journal Articles

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19
Robert L Gottlieb, Gerard J Criner, Onyema Ogbuagu, Kathleen M Mullane, Anuj Gaggar, Diana M Brainard, Gregory Huhn, JAMA
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials
Roy F Chemaly, Kathleen M Mullane, Robin Avery, Raymund R Razonable, Clinical Infectious Diseases
Misdiagnosis of Bordetella Bronchiseptica Respiratory Infection as Bordetella Pertussis by Multiplex Molecular Assay
Vera Tesic, Kathleen Mullane, Kathleen G Beavis, Jennifer Pisano, Moira C McNulty, Jennifer L Steinbeck, David Pitrak, Clinical Infectious Diseases

Lectures

New Insights into the Diagnosis and Treatment of CDI.
Park Ridge, IL - 9/17/2013
New Treatments in the Management of CDI.
Lansing, MI - 8/7/2013
C-Diff Infection: Changing Trends & New Treatments for the Enemy Within.
Englewood, CO - 4/27/2013
The Epidemiologic and Economic Burden of CDI and Treatment Strategies.
St. Louis, MO - 2/26/2013
Management of CDI Infection.
Oak Lawn, IL - 1/3/2013
Clostridium difficile in High Risk Individuals.
Urbana, IL - 9/27/2012
Fidaxomicin and Other Macrocyclic Antibiotics.
San Francisco, CA - 9/1/2012
Risk Factors for CDI in Immunocompromised Hosts.
Kansas City, KS - 8/2/2012
Evolving Treatments for Clostridium.
Springfield, IL - 3/22/2012
Emerging CDI Treatment Options.
University of Chicago - 3/12/2012
Effect of Immune Dysfunction and Diminished Renal Function on CDI outcomes.
University of Chicago - 3/9/2012
Effect of Immune Dysfunction and Diminished Renal Function on CDI Treatment Outcomes.
3/9/2012
New Treatments in the Management of Clostridium difficile Infection.
Detroit, MI - 1/8/2012
Appropriate use of Antifungal Agents; Is this an oxymoron?
Maywood, IL - 12/14/2011
Diagnosis and Management of CDI.
Chicago, IL - 10/31/2011
Reducing the Burden of CDI: From Initial Treatment to Recurrence Prevention.
Ann Arbor, MI - 10/12/2011
New Treatments in the Management of Clostridium difficile Infection.
Alpena, MI - 10/11/2011
New Treatments for CDI.
Chicago, IL - 10/4/2011
Clostridium Difficile: Risks for Infection and Recurrent Disease.
Boston, MA - 10/1/2011
Clostridium Difficile: Pathophysiology, Risk Factors, and Recurrence.
Chicago, IL - 9/17/2011
Updated IDSA Guidelines for the Treatment of Candidemia.
Columbia, SC - 2/8/2011
Pharmacology and Therapeutics: Antimycotic agents.
7/19/2010
Candidemia.
University of Chicago - 10/17/2008
Antifungal Update.
University of Chicago - 8/29/2008
Infections in Solid Organ Transplantation.
University of Illinois, Chicago, IL - 5/23/2008
Join now to see all

Other

Prevention, Diagnosis and Management of Opportunistic Infections in Individuals Living with Chronic Graft versus Host Disease.
Mullane KM, Living with Chronic GVHD; An Educational Symposium for Patients, Families and Healthcare Professiona
http://bmtinfonet.org/
10/30/2010
The 2007 Process of Care (TM) Management of Invasive Fungal Infections: Spectrum of Antifungal Therapies.
Mullane KM, University of Medicine of New Jersey and Dentistry; Center for Continuing and Outreach Education and
12/1/2007
Efficacy and Safety of Echinocandin Prophylaxis against Invasive Fungal Infection during Stem Cell Transplantation.
Mullane KM, University of Medicine of New Jersey and Dentistry Center for Continuing and Outreach Education and
4/1/2005

Authored Content

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
Pubmed bibliograpyJune 2020
Join now to see all

Press Mentions

mRNA Vaccines Get Ready for Their Next Act: Fighting CancerSeptember 21st, 2021
You're More Likely to Have This Symptom with the Delta Variant, Doctors SayAugust 27th, 2021
New Study Shows One Dose of COVID-19 Is Not Enough to Protect Against Delta VariantJuly 8th, 2021
Join now to see all

Professional Memberships

Infectious Disease Society of America - IDSA
Fellow
American Society of Transplantation
Fellow
American Society of Blood and Marrow Transplantation
Member